Z-1301-2018 Class II Terminated
FDA device recall Z-1301-2018 was initiated by The Binding Site Group, Ltd. on Mar 9, 2018 and is designated Class II. Reason for recall: The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use. The recall status is terminated (terminated Jun 22, 2020). Affected quantity: 20 kits distributed to the U.S.
Recall details
- Product Type
- Devices
- Report Date
- Apr 11, 2018
- Initiation Date
- Mar 9, 2018
- Termination Date
- Jun 22, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20 kits distributed to the U.S.
Product description
Reason for recall
Distribution pattern
US Distribution was made to CA. There was no foreign/military/government distribution.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1301-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.